63
Hemophilia during pregnancy Dr Samra Siddiq Post graduate resident Gyane unit 1 Services Hospital

Hemophilia in pregnancy

Embed Size (px)

Citation preview

Page 1: Hemophilia in pregnancy

Hemophilia during pregnancy

Dr Samra Siddiq Post graduate resident Gyane unit 1 Services

Hospital

Page 2: Hemophilia in pregnancy

Royal Disease “Hemophilia”

Page 3: Hemophilia in pregnancy

Items to be discussed in this talk

• What is hemophilia?• Types• Incidence• Genetics• Clinical presentation• Investigations• Management• Hemophilia AND pregnancy• Cases

Page 4: Hemophilia in pregnancy

Items to be discussed in this talk

• What is hemophilia?• Types• Incidence• Genetics• Clinical presentation• Investigations• Management• Hemophilia AND pregnancy• Cases

Page 5: Hemophilia in pregnancy

What is Hemophilia?

• HEMO = BLEEDING• PHILIA = LOVE

• Hemophilia = The Love of Bleeding

Page 6: Hemophilia in pregnancy

Genetic disease of blood coagulation

Page 7: Hemophilia in pregnancy

What is Hemophilia?

• Hemophilia is a hereditary bleeding disorder caused by deficiency of coagulation factor VIII, IX or XI.

• The deficiency is the result of mutations in the respective clotting factor genes.

Page 8: Hemophilia in pregnancy
Page 9: Hemophilia in pregnancy

Items to be discussed in this talk

• What is hemophilia?• Types• Incidence• Genetics• Clinical presentation• Investigations• Management• Hemophilia AND pregnancy• Historical facts

Page 10: Hemophilia in pregnancy

Types

• Hemophilia A 80%– Classic hemophilia – Factor VIII deficiency

• Hemophilia B 20%– Christmas disease – Factor IX deficiency

• Hemophilia C Very rare– Factor XI deficiency

Page 11: Hemophilia in pregnancy

• PARAHAEMOPHILIA• ACQUIRED HAEMOPLILIA

Page 12: Hemophilia in pregnancy

Items to be discussed in this talk

• What is hemophilia?• Types• Incidence• Genetics• Clinical presentation• Investigations• Management• Hemophilia AND pregnancy• Historical facts

Page 13: Hemophilia in pregnancy

Incidence

• Hemophilia is quite rare.• Mainly affects males.

• Hemophilia A: 1 in 10,000 live births.• Hemophilia B: 1 in 50,000 live births.• Heamophilia C : 1 in 1 million

Page 14: Hemophilia in pregnancy

Items to be discussed in this talk

• What is hemophilia?• Types• Incidence• Genetics• Clinical presentation• Investigations• Management• Hemophilia AND pregnancy• Historical facts

Page 15: Hemophilia in pregnancy

Genetics

• Hemophilia inheritance is classically described as an X linked recessive trait, leading to mutation in F8 or F9 gene.

• Mainly affects males.• Females are usually carriers.

• However, spontaneous mutations are described in 20-30% of hemophiliacs.

Page 16: Hemophilia in pregnancy

Different Cases1. Carrier Mother + Non-hemophiliac Father

Each pregnancy has a 25% chance of resulting in a female non-carrier, a 25% chance of a female carrier, a 25% chance of non-hemophiliac male, and a 25% chance of a male with hemophilia.

Page 17: Hemophilia in pregnancy

Different Cases2. Non-carrier Mother + Father With Hemophilia

Each pregnancy has a 50% chance of a female carrier and a 50% chance of a non-hemophiliac male.

Sons of hemophiliac fathers and non-carrier mothers will not have hemophilia (their X is always maternal).

Page 18: Hemophilia in pregnancy

Different Cases3. Carrier Mother + Father With Hemophilia

Each pregnancy has a 25% chance of a female carrier, a 25% chance of a female with hemophilia, a 25% chance of a non-hemophiliac male, and a 25% chance of a male with hemophilia.

Page 19: Hemophilia in pregnancy

Different Cases4. Mother With Hemophilia + Father With Hemophilia

Each pregnancy has a 50% chance of resulting in a female with hemophilia and a 50% chance of resulting in a male with hemophilia.

Page 20: Hemophilia in pregnancy

Different Cases5. Mother With Hemophilia + Non-hemophiliac Father

Each pregnancy has a 50% chance of resulting in a female carrier and a 50% chance of resulting in a male with hemophilia.

Page 21: Hemophilia in pregnancy

How is a female affected?

• Mother With Hemophilia + Father With Hemophilia.

• Carrier Mother + Father With Hemophilia.• Turner syndrome (45 X0).• Lyonised (inactive) X chromosome.

N.B. Carriers usually have enough clotting factors from their normal X chromosome which prevent serious bleeding problems.

Page 22: Hemophilia in pregnancy

Items to be discussed in this talk

• What is hemophilia?• Types• Incidence• Genetics• Clinical presentation• Investigations• Management• Hemophilia AND pregnancy• Historical facts

Page 23: Hemophilia in pregnancy

Clinical presentation

• The characteristic phenotype in hemophilia is the bleeding tendency.

• History of bleeding is usually life-long.• The severity of bleeding in hemophilia is

generally correlated with the clotting factor level.but not in case of haemophilia C.

Page 24: Hemophilia in pregnancy

Clinical presentation

Severity Factor VIII level PresentationMild 5-30% of normal

(6-40 IU/dl)-Severe bleeding after major trauma or surgery-Spontaneous bleeding is rare-May be asymptomatic

Moderate 1-5% of normal(1-5 IU/dl)

-Prolonged bleeding after minor trauma or surgery-Occasional spontaneous bleeding

Severe <1% of normal(< 1 IU/dl)

-Spontaneous bleeding into joints or muscles, without identifiable hemostatic challenge-May be serious & life threatening

Page 25: Hemophilia in pregnancy

Items to be discussed in this talk

• What is hemophilia?• Types• Incidence• Genetics• Clinical presentation• Investigations• Management• Hemophilia AND pregnancy• Historical facts

Page 26: Hemophilia in pregnancy

Investigations

• Platelet count: Normal• Bleeding time: Normal• PT: Normal• Clotting time & APTT: Prolonged• Factor VIII or Factor IX assay: Decreased

Page 27: Hemophilia in pregnancy

Items to be discussed in this talk

• What is hemophilia?• Types• Incidence• Genetics• Clinical presentation• Investigations• Management• Hemophilia AND pregnancy• Historical facts

Page 28: Hemophilia in pregnancy

Management

• Prevention of bleeding episodes.• Replacement therapy.• Prophylactic therapy.• Other lines of therapy.• Management of complications.

Page 29: Hemophilia in pregnancy

Management

• Prevention of bleeding episodes.• Replacement therapy.• Prophylactic therapy.• Other lines of therapy.• Management of complications.

Page 30: Hemophilia in pregnancy

1. Prevention of bleeding episodes.

• Toys that do not have sharp edges.• Using soft and stuffed toys.• Padding the crib.• Using helmets & pads to protect elbows and

knees.• Avoid games like football.• Using soft tooth brushes.• Careful usage of sharp razors.• Wear Medic Alert ID.

Page 31: Hemophilia in pregnancy

Management

• Prevention of bleeding episodes.• Replacement therapy.• Prophylactic therapy.• Other lines of therapy.• Management of complications.

Page 32: Hemophilia in pregnancy

2. Replacement therapy

• Indication:Bleeding or Injury

Page 33: Hemophilia in pregnancy

2. Replacement therapy

• Fresh whole blood• Whole plasma• Fresh Frozen Plasma• Cryoprecipitate• Factor VIII or IX Concentrate• Recombinant Factor VII (Novo-Seven): to

bypass factor VIII in the coagulation pathway

Page 34: Hemophilia in pregnancy

Factor VIII Concentrate

• Factor VIII Concentrate:20 U/kg increases the level by ± 50%.

Clinical Situation Raise factor VIII up toMild bleeding 20-40%

Severe or life threatening bleeding

100%

Page 35: Hemophilia in pregnancy

Management

• Prevention of bleeding episodes.• Replacement therapy.• Prophylactic therapy.• Other lines of therapy.• Management of complications.

Page 36: Hemophilia in pregnancy

3. Prophylactic therapy

• Indication:Before surgeryAfter exposure to trauma

• Lines:ReplacementOther lines

Page 37: Hemophilia in pregnancy

Management

• Prevention of bleeding episodes.• Replacement therapy.• Prophylactic therapy.• Other lines of therapy.• Management of complications.

Page 38: Hemophilia in pregnancy

4. Other lines of therapy

• Desmopressin:

- Action: stimulates the release of stored factor VIII and von Willebrand factor. von Willebrand factor carries and binds factor VIII, which then can stay in the blood stream longer.

-Administration: Injection or Nasal spray.

-Use:Before dental work.For treating mild bleeding from the mouth or nose.

Page 39: Hemophilia in pregnancy

4. Other lines of therapy

• EACA (e –amino caproic acid): - Action: Antifibrinolytic delays clot lysis

-Use: Adjuvant therapy for dental procedures

Page 40: Hemophilia in pregnancy

4. Other lines of therapy

• Fibrin Glue: - Action: Contains fibrinogen, thrombin and factor XIII. Placed in the site of injury to stabilize clot.

-Use: Dental procedures and after circumcision

Page 41: Hemophilia in pregnancy

Items to be discussed in this talk

• What is hemophilia?• Types• Incidence• Genetics• Clinical presentation• Investigations• Management• Hemophilia AND pregnancy• Historical facts

Page 42: Hemophilia in pregnancy

Hemophilia AND Pregnancy

• Pre-conceptional management.• Antenatal management.• Management during delivery.• Postpartum management

Page 43: Hemophilia in pregnancy

Pre-conceptional management

• Counseling:Whenever the mother has hemophilia A or B, all of her sons will have the disease, and all of her daughters will be carriers. If she is a carrier, half of her sons will inherit the disease and half of her daughters will be carriers.

• Pre-implantation genetic diagnosis: has been recently introduced for hemophilia since 2007.

Page 44: Hemophilia in pregnancy

• Prenatal diagnosis: by CVS.(best method)

• Amniocentesis • Cordocentesis (factor level)• Fetal cells in maternal blood.• Sex determination by USG at 11 week

Page 45: Hemophilia in pregnancy
Page 46: Hemophilia in pregnancy

•ANTENATAL MANAGEMENT•Factor VIII usually increases in pregnancy•Replacement rarely required ….mostly in early pregnancy events (ectopic,miscarriage,CVS,amniocentesis)•Factor IX level does not increase in pregnancy.more haemostatic support would be required in form of recombinant factors.•No role desmopressin in haemophilia B•In case of replacement therapy hep A and B immunization should be checked.

Page 47: Hemophilia in pregnancy

• Clotting factors level should be checked at booking ,28 week,34 weeks

• If level is 50 IU/dl it is sufficient to avoid bleeding in pregnancy,diagnostic procedures,SVD,C/S.

• If greater than 50IU/dl then sufficient for local anesthesia.

Page 48: Hemophilia in pregnancy

Fator XI level shows no change in pregnancy although some individuals show gradual declineLevel should be checked at booking,28 weeks,34 weeks,prior to invasive procedures.If level is < than 15IU/dl then 16-30% chances of bleeding.prophylasix should be given on daily basis till level rises to 70IU/dlNOTE…level should not be greater than 100IU/dl (associated with thrombosis)If patient has history of thrombosis or atherosclerosis factor replacement is not advisable alternative support should be given with FFP,transamin.

Page 49: Hemophilia in pregnancy

INTRAPARTUM MANAGEMENT

• Time: according to obstetric indications• mode: controversial.• Should be least traumatic• SVD is preffered mode• main concern is intracerebral bleeding so complicated

forceps delivery, rotational foceps,ventouse extraction,scalp electrodes,fetal blood sampling should be avioded.

• Low cavity forceps can be considered• If there is delay in labour or safe vaginal delivery is less

likely then do C/S.

Page 50: Hemophilia in pregnancy

•On admissiom to labour suit……•CBC

•Coagulation profile•Cross match blood•Clotting factors level

•If clotting factor level is < than 50 IU/dl then•I/m anelgesis should be avoided•Suspect baby to be haemophilic

Reduce risk of bleeding by: avoiding lacerations, minimizing episiotomy use and size, and by maximizing postpartum myometrial contractions and retraction

Page 51: Hemophilia in pregnancy

Management after delivery

NEOBORN Cord blood should be taken to determine clotting factors

level.Vit k prophylasix should be given by oral rather than I/mVaccines should be given by S/C routeScreening for congenital hip dislocation should be

delayed till factors level availableIf clotting factors level is decreased and delivery was

traumatic baby should be screened for intracranial bleed by USG and CT brain.

Page 52: Hemophilia in pregnancy

In hamophilia A factor VIII level fall quickly to pre pregnancy level

Level shoul b maimtained at 50IU/dl for 3 days in SVD and or 5 days in C/S.

Desmopressin can be given as it does not enter breast milk.

Page 53: Hemophilia in pregnancy

First DeliveryUpon presentation, the patient was without any recent

bleeding. Her FVIII activity level was 0.94 IU /dLand her FVIII inhibitor by Bethesda Assay was negative

4 months prior to her pregnancy. She began prophylaxiswith recombinant FVIII concentrate (Recombinate, BaxterBioscience), at a dose of 40 U/kg ,twice weekly starting inher second trimester. At 72 hours her FVIII activity level

was 7 IU/dL. Care was coordinated with the high-riskobstetrical team. There were no bleeding complications

during the pregnancy.

Page 54: Hemophilia in pregnancy

She was admitted to the hospital for induction of labor at39 weeks of gestation. The labor was induced at term to

ensure adequate control of factor levels and minimize therisks of bleeding. During the labor and delivery period, factor

levels were continuously monitored by the laboratory toavoid obstetric complications. Her physical exam was

unremarkable, with no evidence of ecchymoses, petechiae, purpura, or vaginal bleeding. On laboratory examination white

blood cell count was 7.4 hemoglobin 11.6 g/ dL

platelets 249 prothrombin time (PT) 14.1 seconds

activated partial thromboplastin time (aPTT) 32 seconds, andFVIII activity of 7 IU/dl.

Page 55: Hemophilia in pregnancy

• The patient received a bolus infusion of Recombinate 50 U/kg

• with a 1-hour peak FVIII activity of 111 IU/ dL

• and an 8-hour trough level of 75 IU /dL• This was followed by 25 U/ kg• every 8 hours intravenously to maintain

her FVIII activity level between 50 IU/ dL- 100 IU /dL until delivery.

Page 56: Hemophilia in pregnancy

Morphine, Nubain (EndoPharmaceuticals, Chadds Ford,PA), and Phenergan (Baxter Healthcare Corp., Deerfield, IL)were administered intravenously for analgesia during labouras she refused epidural anesthesia. A female baby was delivered by vaginal delivery after 36 hours of labour.

Page 57: Hemophilia in pregnancy

blood loss of 150 mL. No excessive bleeding was noted duringcord clamping. Cord blood sample obtained from the babyrevealed FVIII activity of 86 IU/ dLThe patient’spostpartumcourse was uncomplicated and mother and daughter weredischarged after 3 days continuing on Recombinate for6 weeks postpartum.

Page 58: Hemophilia in pregnancy

Dosing was as followed: 25 U/ kg every 12 hours days 2 to 5 25 U /kg daily days 6 to 14 and25 U/ kgevery other day until cessation of postpartumvaginal spotting at 6 weeks. The patient was slightly anemic atdischarge with hemoglobin of 10 g/ dL A 6-week postpartum Bethesda Assay was negative for an FVIII inhibitor.

Page 59: Hemophilia in pregnancy

Second DeliveryTwo years later the patient presented again at 8 weeks ofgestation. Her FVIII activity level was 1 IU/ dL.at baseline her FVIII inhibitor by Bethesda Assay was negative. Againprophylaxis with recombinant FVIII concentrate (Recombinate) at a dose of 40 U/ kg twice weekly was started in thesecond trimester. A 72-hour FVIII activity trough level was 7.8IU/ dL

Page 60: Hemophilia in pregnancy

She was admitted for induction of labor at 39 weeks ofgestation. Her physical exam showed no evidence of ecchymoses, petechiae, purpura, or vaginal bleeding. On laboratoryexamination white blood cell count was 7.8hemoglobin 10.5 g/ dLplatelets 267PT12.5seconds, and aPTT 39 seconds. Her FVIII activity was 35 IU/ dLat22 hours after her last treatment. The same protocol of bolusrecombinant FVIII concentrate and induction of labor utilizedin thefirst delivery was used in the second delivery.

Page 61: Hemophilia in pregnancy

The peakFVIII activity was 105 IU/ dLand an 8-hour trough level was63 IU/ dLand her FVIII activity level was maintainedbetween 50 and 100 IU dLuntil delivery.Intravenous morphine, Nubain, and Phenergan were administered intravenously for analgesia.

Page 62: Hemophilia in pregnancy

A female baby wasdelivered after 20 hours of labor. The total blood loss from theuncomplicated vaginal delivery was 200 mL. There was noexcessive bleeding during cord clamping. She experiencedminimum postpartum bleeding and the patient and daughterwere discharged after 4 days with a hemoglobin of 9.4 g /dLcontinuing on Recombinate for 6 weeks postpartum as described post–first delivery

Page 63: Hemophilia in pregnancy

THANK YOU